Komori
Freesia Macross (6343) · FactAdvanced

Equity-method accounting for Solekia Limited and investment gain from negative goodwill

First written in FY2018-Q1. 18 of 36 entries say "Advanced", first in FY2018-Q2. Latest entry: 2026-11-16.

36entries
10years
5from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseWorsenedFY2024-Q1 – FY2024-Q3AdvancedFY2025-H1 – 2026-11-162017: 220172018: 420182019: 420192020: 420202021: 420212022: 420222023: 420232024: 220242025: 120252026: 72026
Same theme, other companies
Investment gain from negative goodwill arising on commencement of equity-method accountingA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2027-H1AdvancedAnnual report

    「Share of profit of entities accounted for using the equity method ¥397,546 thousand ¥462,327 thousand」

    Share of profit of entities accounted for using the equity method increased from ¥397,546 thousand in the previous interim period to ¥462,327 thousand, making a greater contribution to the increase in ordinary income.
  2. 2026-08-14AdvancedResults

    「持分法による投資利益 198,515 250,490」

    持分法による投資利益は前年同四半期の198,515千円から250,490千円へ増加し、経常利益の増加要因としての寄与が拡大した。
  3. FY2026AdvancedAnnual report

    「This was due to a ¥216 million increase in investment income under the equity method, a ¥39 million increase in interest expenses, and other factors.」

    Investment income under the equity method increased by ¥216 million year on year, expanding its contribution as a factor behind the increase in ordinary income.
  4. FY2026-H1AdvancedAnnual report

    「In the current interim consolidated accounting period, net sales increased by ¥120 million (3.5%) from the previous interim consolidated accounting period to ¥3,532 million. Operating income increased by ¥180 million (29.8%) to ¥784 million, and ordinary income increased by ¥275 million (27.5%) to ¥1,276 million due to improved performance by equity-method affiliates.」

    Improved performance by equity-method affiliates was cited as a factor behind the increase in ordinary income, and investment income under the equity method increased from ¥314.623 million in the previous interim period to ¥397.546 million.
  5. FY2025-H1AdvancedAnnual report

    「Operating income increased by ¥83 million (16.0%) from the previous interim consolidated accounting period to ¥604 million, while ordinary income increased by ¥238 million (31.4%) to ¥1,000 million due to improved performance by equity-method affiliates.」

    Improved performance by equity-method affiliates was cited as a factor behind the increase in ordinary income, and investment income under the equity method increased from ¥198.249 million in the previous interim period to ¥314.623 million.
  6. FY2024-Q3WorsenedAnnual report

    「Ordinary income decreased by ¥211 million (16.0%) from the same quarter of the previous year to ¥1,111 million, due to deterioration in the performance of some equity-method affiliates.」

    Due to the deterioration in the performance of some equity-method affiliates, investment income under the equity method decreased from ¥367.778 million in the same period of the previous year to ¥288.199 million, becoming a factor behind the decline in ordinary income.
  7. FY2024-Q2WorsenedAnnual report

    「Ordinary income decreased by ¥116 million (13.2%) from the same quarter of the previous year to ¥761 million, due to deterioration in the performance of some equity-method affiliates.」

    Due to the deterioration in the performance of some equity-method affiliates, investment income under the equity method decreased from ¥303.348 million in the same quarter of the previous year to ¥198.249 million, becoming a factor behind the decline in ordinary income.
  8. FY2024-Q1WorsenedAnnual report

    「Investment income under the equity method 150,867 84,748」

    Investment income under the equity method decreased from ¥150.867 million in the same quarter of the previous year to ¥84.748 million, becoming a factor behind the decline in ordinary income. The boost from the recovery in the performance of equity-method affiliates that had continued from the previous fiscal year has weakened.
  9. FY2023AdvancedAnnual report

    「Non-operating income was ¥907 million, up ¥125 million (16.1%) from the same period of the previous year. This was due to an ¥82 million increase in investment income under the equity method, a ¥77 million decrease in fees paid, and other factors.」

    Investment income under the equity method increased from ¥483.575 million in the same period of the previous year to ¥566.270 million, continuing to contribute to the increase in ordinary income.
  10. FY2023-Q3AdvancedAnnual report

    「Investment income under the equity method 319,848 367,778」

    Investment income under the equity method increased from ¥319.848 million in the same quarter of the previous year to ¥367.778 million. The recovery in the performance of equity-method affiliates continued to be cited as a factor behind the increase in ordinary income.
  11. FY2023-Q2AdvancedAnnual report

    「Ordinary income increased by ¥108 million (14.0%) from the same quarter of the previous year to ¥877 million, due to the recovery in the performance of equity-method affiliates.」

    The recovery in the performance of equity-method affiliates continued to be cited as a factor behind the increase in ordinary income, and investment income under the equity method increased from ¥290.786 million in the same period of the previous year to ¥303.348 million.
  12. FY2023-Q1RestatedAnnual report

    「Following the increase in operating income and the recovery in the performance of equity-method affiliates, ordinary income increased by ¥73 million (21.9%) from the same quarter of the previous year to ¥409 million.」

    The recovery in the performance of equity-method affiliates continued to be cited as a factor behind the increase in ordinary income. Investment income under the equity method was ¥150.867 million, down from ¥161.842 million in the same quarter of the previous year, but income recognition continued.
  13. FY2022AdvancedAnnual report

    「Non-operating expenses were ¥281 million, down ¥172 million (38.1%) from the same period of the previous year. This was mainly because, following the recovery in the performance of equity-method affiliates, the investment loss under the equity method of ¥240 million in the previous period became investment income under the equity method of ¥483 million in the current period.」

    The recovery in the performance of equity-method affiliates caused the investment loss under the equity method of ¥240 million to turn into investment income of ¥483 million. As a result, the factor affecting ordinary income changed from a deterioration in the previous year to an improvement.
  14. FY2022-Q3AdvancedAnnual report

    「Investment income under the equity method - 319,848」

    Investment income under the equity method of ¥319.848 million was recognized, an improvement from the investment loss under the equity method of ¥447.241 million in the same quarter of the previous year. The recovery in the performance of equity-method affiliates was cited as a factor behind the increase in ordinary income.
  15. FY2022-Q2AdvancedAnnual report

    「Investment income under the equity method - 290,786」

    Investment income under the equity method of ¥290.786 million was recognized, an improvement from the investment loss under the equity method of ¥103.132 million in the same quarter of the previous year. The analysis of operating results also identifies the recovery in the performance of equity-method affiliates as a factor behind the increase in ordinary income.
  16. FY2022-Q1AdvancedAnnual report

    「Investment income under the equity method 76,246 161,842」

    Investment income under the equity method increased from ¥76.246 million in the same quarter of the previous year to ¥161.842 million. The analysis of operating results cites the recovery in the performance of equity-method affiliates as a factor behind the increase in ordinary income.
  17. FY2021WorsenedAnnual report

    「Although the performance of the other equity-method affiliates remained solid, the significant deterioration in the performance of LAPINE CO.,LTD. following the spread of COVID-19 was the main reason that investment income under the equity method of ¥602 million in the previous period became an investment loss under the equity method of ¥240 million in the current period.」

    Due to the deterioration in LAPINE CO.,LTD.'s performance, investment income under the equity method of ¥602 million turned into an investment loss of ¥240 million, becoming a factor behind the decline in ordinary income.
  18. FY2021-Q3WorsenedAnnual report

    「Ordinary income decreased by ¥738 million (76.1%) from the same quarter of the previous year to ¥232 million, following a ¥761 million decrease in investment income under the equity method, mainly because the performance of LAPINE CO.,LTD., an equity-method affiliate of the Company, deteriorated significantly. The quarterly net loss attributable to owners of the parent was ¥503 million (a decrease of ¥207 million from the same quarter of the previous year).」

    LAPINE CO.,LTD.'s performance deteriorated significantly, and investment income under the equity method decreased by ¥761 million year on year. The income statement also recorded an investment loss under the equity method of ¥447 million, worsening the contribution to ordinary income and income attributable to owners of the parent.
  19. FY2021-Q2WorsenedAnnual report

    「Ordinary income decreased by ¥405 million (58.9%) from the same quarter of the previous year to ¥282 million following a ¥337 million decrease in investment income under the equity method, while the quarterly net loss attributable to owners of the parent was ¥104 million (compared with quarterly net income attributable to owners of the parent of ¥242 million in the same quarter of the previous year).」

    Investment income under the equity method decreased by ¥337 million year on year, becoming a factor behind the decline in ordinary income. The income statement also recorded an investment loss under the equity method of ¥103 million in the current period, resulting in a quarterly net loss attributable to owners of the parent.
  20. FY2021-Q1ReframedAnnual report

    「Investment income under the equity method 100,118 76,246」

    Investment income under the equity method decreased from ¥100.118 million in the same period of the previous year to ¥76.246 million. Investment income from equity-method investees has continued, although its contribution has changed.
  21. FY2020ReframedAnnual report

    「Ordinary income increased by ¥325 million (33.7%) from the same period of the previous year to ¥1,290 million, due to increases in operating income and investment income under the equity method.」

    Because of the temporary factor of negative goodwill arising from accounting for Solekia under the equity method, the increase in investment income under the equity method was cited as a factor behind the increase in ordinary income for the current period, changing the composition of profit.
  22. FY2020-Q3AdvancedAnnual report

    「Investment income under the equity method 258,332 314,497」

    Investment income under the equity method increased from ¥258.332 million in the same period of the previous year to ¥314.497 million, and investment income from equity-method investees has continued.
  23. FY2020-Q2RestatedAnnual report

    「Investment income under the equity method 234,000」

    ¥234 million of investment income from equity-method investees was recognized, reconfirming that investment income associated with accounting for Solekia Limited and other companies under the equity method has continued.
  24. FY2020-Q1RestatedAnnual report

    「Investment income under the equity method 93,387 100,118」

    ¥100.118 million of investment income under the equity method was recognized in the first quarter, reconfirming that investment income from equity-method investees has continued.
  25. FY2019RestatedAnnual report

    「Non-operating income was ¥450 million, down ¥163 million (26.7%) from the same period of the previous year. This was mainly due to a decrease in investment income under the equity method.」

    While investment income from equity-method investees, including Solekia Limited, has continued, the decrease in investment income under the equity method due to the reversal of the negative goodwill recognized in the same period of the previous year and other factors has been reconfirmed.
  26. FY2019-Q3ReframedAnnual report

    「Ordinary income was ¥815 million, down ¥166 million (16.9%) from the same quarter of the previous year, because there was no negative goodwill related to the conversion of Solekia Limited into an equity-method affiliate, which had arisen in the same quarter of the previous year.」

    While investment income from accounting for Solekia Limited under the equity method was recognized, the negative goodwill related to its conversion into an equity-method affiliate, which arose in the same period of the previous year, was absent in the current quarter, changing the composition of profit.
  27. FY2019-Q2ReframedAnnual report

    「Ordinary income was ¥505 million, down ¥240 million (32.2%) from the same quarter of the previous year, because there was no negative goodwill related to the conversion of Solekia Limited into an equity-method affiliate, which had arisen in the same quarter of the previous year.」

    Solekia Limited has continued to be accounted for under the equity method, but the negative goodwill related to its conversion into an equity-method affiliate, which was recognized in the same period of the previous year, was absent in the current quarter, changing the composition of investment income.
  28. FY2019-Q1ReframedAnnual report

    「Ordinary profit was ¥88 million, down ¥322 million, or 78.5%, from the same quarter of the previous year. This was despite investment income under the equity method arising from the additional acquisition of shares in Solekia Limited and other factors, because the ¥366 million share of investment income under the equity method attributable to negative goodwill relating to equity-method affiliates recorded in the cumulative first-quarter period of the previous consolidated fiscal year was no longer recorded.」

    While investment income under the equity method from the additional acquisition of shares in Solekia Limited has continued, the ¥366 million investment income from negative goodwill recognized in the first quarter of the previous fiscal year has disappeared, changing the composition of investment income.
  29. FY2018AdvancedAnnual report

    「In addition, because an equity-method investment gain of ¥460 million related to Solekia Limited, which newly became an equity-method affiliate, was recorded, ordinary income increased by ¥508 million, or 88.6%, year on year to ¥1,082 million」

    Equity-method accounting for Solekia Limited continued throughout the fiscal year, and the ¥460 million equity-method investment gain was disclosed as a factor contributing to the increase in ordinary income.
  30. FY2018-Q3RestatedAnnual report

    「In addition, because an equity-method investment gain of ¥393 million related to Solekia Limited, which newly became an equity-method affiliate, was recorded, ordinary income increased by ¥521 million, or 113.4%, year on year to ¥981 million」

    Equity-method accounting for Solekia Limited continued, and the ¥393 million equity-method investment gain was recorded as a factor contributing to the increase in ordinary income.
  31. FY2018-Q2AdvancedAnnual report

    「Following the additional acquisition of shares in Solekia Limited, the company was included in the scope of equity-method accounting from the first quarter of the fiscal year under review. In addition, because an equity-method investment gain of ¥404 million related to Solekia Limited, which newly became an equity-method affiliate, was recorded, ordinary income increased by ¥540 million, or 262.5%, year on year to ¥746 million.」

    Equity-method accounting for Solekia Limited continued in the second quarter, and the ¥404 million equity-method investment gain was recorded as a factor contributing to the increase in ordinary income.
  32. FY2018-Q1First statedAnnual report

    「Following the additional acquisition of shares in Solekia Limited, the company was included in the scope of equity-method accounting from the first quarter of the fiscal year under review. In addition, because ¥366 million of negative goodwill related to Solekia Limited, an equity-method affiliate, was recorded as an equity-method investment gain, ordinary income was ¥410 million, compared with an ordinary loss of ¥37 million in the same quarter of the previous year, and net income attributable to owners of the parent was ¥347 million, an increase of ¥318 million, or 1,130.0%, from the same quarter of the previous year.」

    The application of the equity method following the additional acquisition of Solekia Limited and the recording of ¥366 million in negative goodwill as an equity-method investment gain were disclosed as factors contributing to increases in ordinary income and net income attributable to owners of the parent for the quarter.
Moved together

"Increase in Operating Profit and Ordinary Profit Despite Declining Sales" moved the same way as this thread, in the same document, in 18 of its 36 moves.

181514121210★123456
  1. ★This thread
  2. 1Increase in Operating Profit and Ordinary Profit Despite Declining Sales18×
  3. 2Strengthening and improving the soundness of the financial base and management structure15×
  4. 3High-margin formwork manufacturing sales driven by reconstruction demand and improved profitability in the manufacturing and supply business14×
  5. 4Funding and Liquidity Management Centered on Bank Borrowings12×
  6. 5Lower condominium revenue and improved profitability due to a higher proportion of existing-home services12×
  7. 6A Challenging Competitive Environment and Domestic and Overseas Economic and Demand Trends10×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Freesia Macross's next results are scheduled for 2026-11-16. Read the earnings preview It last moved in the Timely disclosure of 2026-11-16: "Cited as achieved".
Equity-method accounting for Solekia Limited and investment gain from negative goodwill | FREESIA MACROSS CORPORATION (6343) | Komori